House dust mite subcutaneous immunotherapy has sustained long ‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up

ConclusionsSustained clinical efficacy is achieved 10 years after completion of depigmented-polymerized HDM, however, these findings were observed only if patients are treated for at least 3 years.

Source: Immunity, Inflammation and Disease - October 14, 2023 Category: Allergy & Immunology Authors: Elena Rodriguez ‐Plata, Ariel Callero Viera, Monica Ruiz‐Garcia, Aida Gomez‐Cardenosa, Eva Nieto, Jose Carlos García‐Robaina Tags: ORIGINAL ARTICLE Source Type: research